Virpax Pharmaceuticals Inc.

05/14/2024 | Press release | Distributed by Public on 05/15/2024 04:36

Notice of Effectiveness - Form EFFECT

Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: May 14, 2024 5:00 P.M.
Form: S-1
CIK: 0001708331
Company Name: Virpax Pharmaceuticals, Inc.
File Number: 333-278796